|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 3, 823-835, March 2003
Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, Rhode Island 02912
Submitted October 11, 2002; Revised October 11, 2002; Accepted November 6, 2002| |
ABSTRACT |
|---|
|
|
|---|
c-myc is an important protooncogene whose
misregulation is believed to causally affect the development of
numerous human cancers. c-myc null rat fibroblasts are
viable but display a severe (two- to threefold) retardation of
proliferation. The rates of RNA and protein synthesis are reduced by
approximately the same factor, whereas cell size remains unaffected. We
have performed a detailed kinetic cell cycle analysis of
c-myc
/
cells by using several labeling
and synchronization methods. The majority of cells (>90%) in
asynchronous, exponential phase c-myc
/
cultures cycle continuously with uniformly elongated cell cycles. Cell
cycle elongation is due to a major lengthening of G1 phase (four- to fivefold) and a more limited lengthening of G2
phase (twofold), whereas S phase duration is largely unaffected.
Progression from mitosis to the G1 restriction point and the subsequent
progression from the restriction point into S phase are both
drastically delayed. These results are best explained by a model in
which c-Myc directly affects cell growth (accumulation of mass) and
cell proliferation (the cell cycle machinery) by independent pathways.
| |
INTRODUCTION |
|---|
|
|
|---|
The deregulation of c-myc gene expression is frequently
observed in many diverse human malignancies (Henriksson and Luscher, 1996
; Dang, 1999
). In normal cells the expression of the
c-myc protooncogene is under tight control and is rapidly
induced by mitotic stimuli and suppressed by negative growth signals
(Obaya et al., 1999
; Grandori et al., 2000
). The
c-Myc protein is a transcription factor whose DNA-binding domain
contains basic region, helix-loop-helix, and leucine zipper motifs
(Luscher and Larsson, 1999
). c-Myc forms an obligate heterodimer with
its partner Max and binds to a DNA consensus sequence known as an E-box
[CA(C/T)GTG] (Blackwood and Eisenman, 1991
; Prendergast and Ziff,
1991
; Amati and Land, 1994
). The first 143 N-terminal amino acids
comprise a regulatory domain that can both positively and negatively
modulate the expression of target genes (Claassen and Hann, 1999
; Amati
et al., 2001
). The mechanisms by which c-Myc modulates
target gene transcription are not well understood (Oster et
al., 2002
); activation of target genes has been suggested to
involve processes that impact histone acetylation (McMahon et
al., 1998
; McMahon et al., 2000
; Frank et
al., 2001
), ATP-dependent chromatin remodeling (Cheng et
al., 1999
; Wood et al., 2000
), and promoter clearance
(Eberhardy and Farnham, 2001
). Repression of target genes has been
reported to involve interference with the initiator element
(Inr)-binding activator Miz-1 (Staller et al., 2001
), but
Inr-independent repression has also been reported by several groups
(Facchini et al., 1997
; Xiao et al., 1998
; Yang
et al., 2001
).
c-myc knockout mice display numerous developmental
abnormalities and die at day 10.5 of gestation (Davis et
al., 1993
). A homozygous c-myc knockout in a rat
fibroblast cell line is not lethal but the cells display a severe
retardation of proliferation (Mateyak et al., 1997
).
Drosophila c-myc null mutants have not been reported, but
hypomorphic null alleles display a diminutive phenotype and female
sterility (Gallant et al., 1996
; Schreiber-Agus et
al., 1997
). A mosaic analysis in the wings showed that ablation of
dMyc expression resulted in a decrease in cell size but not in the
number of cells, whereas overexpression caused cells to become larger
without affecting the rate of cell division (Johnston et
al., 1999
). Further results from mammalian cells showing that c-Myc overexpression can trigger an increase in cell size (Iritani and
Eisenman, 1999
; Beier et al., 2000
) led to proposals that the primary target of Myc activity may be the accumulation of cell mass
(Elend and Eilers, 1999
; Schmidt, 1999
; Schuhmacher et al.,
1999
). However, more recent work utilizing a series of hypomorphic
alleles as well as conditional deletion of c-myc in the
mouse argues that Myc controls cell number but not cell size (Trumpp
et al., 2001
). Expression profiling of c-Myc target genes has not adequately addressed this issue to date, because genes encoding
cell cycle regulators, metabolic enzymes, as well as ribosomal proteins
were found to be affected (Coller et al., 2000
; Greasley
et al., 2000
; Guo et al., 2000
; Nesbit et
al., 2000
; O'Hagan et al., 2000
).
What is critically needed are additional studies addressing the
influence of c-Myc on various aspects of cellular physiology. A cell
culture model in which both copies of the endogenous c-myc gene have been deleted by gene targeting in a rat fibroblast cell line
(Mateyak et al., 1997
) has been used extensively to
investigate the roles of c-Myc in the regulation of transcription, cell
cycle progression, and apoptosis (Mateyak et al., 1999
;
Frank et al., 2001
; Soucie et al., 2001
; Staller
et al., 2001
). Loss of c-myc reduced the rate of
cell division two- to threefold (Mateyak et al., 1997
).
Interestingly, the rate of RNA and protein synthesis was reduced by
approximately the same factor, whereas cell size remained largely
unaffected. A preliminary analysis of cell cycle progression indicated
that G1 and G2 phases were
elongated, whereas the duration of S phase remained relatively constant
(Mateyak et al., 1997
). However, this analysis was limited
to a single method and did not measure kinetically the duration of
individual cell cycle phases, nor did it address whether all cells
cycled with similar kinetics. We therefore undertook a detailed cell cycle analysis of c-myc
/
cells by using
several labeling and synchronization methods. We report herein that the
majority (>90%) of cells in asynchronous, exponential phase
c-myc
/
cultures cycle continuously with
uniformly elongated cell cycles. Cell cycle elongation is due to a
major lengthening of G1 phase and a more limited
lengthening of G2 phase, whereas S phase duration is largely unaffected. The lengthening of G1 is
caused by, in essentially equal measure, a delay in passage through the
restriction (R) point as well as the slowing of the subsequent
progression into S phase.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture
TGR-1 (c-myc+/+) and HO15.19
(c-myc
/
) cells were grown in DMEM
medium supplemented with 10% calf serum (CS) as described previously (Mateyak et al., 1999
). Unless otherwise stated, all
experiments were performed using continuously cycling asynchronous
cultures. Great care was taken to ensure that cultures were maintained
in continuous exponential growth with frequent medium changes and at
low cell density for many generations. To avoid cell-cell contact cultures were split 1:2 (HO15.19) or 1:3 to 1:5 (TGR-1) after reaching
30% confluence. This subculture regimen was maintained continuously in
10-cm dishes for up to 15-18 passages. Cells were used as needed for
various experiments by seeding into appropriate culture vessels. The
mitotic fraction of cells was harvested by mechanical shake-off without
the use of drugs. To collect mitotic cells a large number of 10-cm
dishes containing asynchronously cycling, exponential phase cultures
were gently tapped against a hard surface. The medium was collected,
cells were recovered by brief low-speed centrifugation, resuspended in
a small amount of medium, and plated into 24-well microtiter dishes.
Growth curves were performed by seeding 55,000 cells (~10%
confluence) per 6-cm dish and incubation in an atmosphere of either 20 or 2% O2. Every 24 h cells from three
plates were harvested with trypsin. Cells collected from each dish were
counted in duplicate by using a Coulter Counter. To analyze the effect
of cell density on cell cycle progression cells were seeded at
densities ranging from 2500-25,000 cells/cm2 and
pulse-labeled with BrdU (5-bromo-deoxy-uridine) 16 or 48 h
after plating.
BrdU Incorporation Assays
Labeling experiments were performed in 24-well microtiter plates
unless indicated otherwise. For continuous BrdU labeling, cells were
seeded at 3000-4000 cells/well (700-1000
cells/cm2 or ~5% confluence), and 12-14 h
later the culture medium was removed, cells were washed once in
Dulbecco's phosphate-buffered saline (PBS) lacking magnesium and
calcium, and medium containing 1 µg/ml BrdU (3.2 µM) and 1 mg/ml
uridine (4.1 mM) was added. In mitotic shake-off experiments harvested
cells were allowed to attach for 2 h (TGR-1) or 4 h (HO15.19)
before BrdU labeling (thirty 10-cm dishes yielded sufficient mitotic
cells for 12 wells of a 24-well microtiter plate). BrdU incorporation
was stopped at the indicated time points by adding 0.4 M ascorbic acid
(to a final concentration of 67 mM) to the culture medium (Moscovitis and Pardee, 1980
). Pulse labeling with BrdU was performed as detailed above, except that the labeling was stopped after 15, 30, or 60 min as
indicated in the figure legends. Cells were harvested immediately after
the pulse unless otherwise indicated. To observe labeled mitoses cells
were seeded in 6-cm dishes at 700-1000 cells/cm2,
pulse labeled with BrdU for 30 min, washed twice with PBS, and the
incubation was continued in fresh medium containing 8 µg/ml (32 µM)
thymidine. All BrdU-containing cultures were handled in a darkened room
with only indirect orange illumination.
In Situ Histochemical Staining of BrdU Incorporation
Plates were washed three times with PBS, and the cells were fixed for 10 min with ice-cold 100% methanol. After three further PBS washes, DNA was denatured using 1.5 M HCl for 1 h at room temperature. The HCl was neutralized by three washes over a 10-min period (~3 min/wash) with 0.1 M borate buffer, pH 8.5, followed by three further PBS washes. Blocking was performed with PBS containing 0.1% (wt/vol) bovine serum albumin (PBSA) for 1 h at 37°C. Incubation with anti-BrdU monoclonal antibody (mAb) (catalog no. 555 627; BD PharMingen, San Diego, CA) was for 1 h at 37°C. Antibody was diluted 1:100 to 1:200 (5-2.5 µg/ml) in PBSA. Subsequently, the Vectastain Elite ABC and Novared kits (Vector Laboratories, Burlingame, CA) were used according to the manufacturer's instructions.
Double Staining for 5-Chloro-deoxy-uridine (CldU)- and 5-Iodo-deoxy-uridine (IdU)-positive Cells
This procedure was adapted from a protocol described by Aten
et al. (1992). Exponentially growing cells in 24-well
microtiter plates were washed twice in PBS followed by a 30-min
incubation in medium containing 10 µM (2.6 µg/ml) CldU. After the
labeling the cells were washed twice in PBS and then incubated for
1 h in medium containing 200 µM thymidine (48.5 µg/ml). After
two brief washes with PBS incubation was continued in unsupplemented medium. At the indicated time points, the medium was removed, cells
were washed twice with PBS, and incubated for 30 min in medium
containing 10 µM (3.5 µg/ml) IdU, at which point the cells were
fixed and denatured as described above. Neutralized cells were washed
three times with PBS containing 0.05% Tween 20 (PBS-T) and blocked for
1 h at 37°C in PBS-T containing 1% BSA (PBSA-T). Incubation
with the primary antibodies was for 1 h at room temperature. CldU
was detected with the anti-BrdU rat mAb [clone BU1/75 (ICR1), catalog
no. MAS 250; Harlan, Indianapolis, IN) diluted 1:520 in PBSA-T,
followed by Cy-3-conjugated donkey anti-rat secondary antibody
(catalog no. 712-165-153; Jackson Immunoresearch Laboratories, West
Grove, PA) diluted 1:200 (3.0 µg/ml). IdU was detected with the mouse
monoclonal anti-BrdU antibody (clone B44; catalog no. 347 580; BD
Biosciences, San Jose, CA; Gratzner, 1982
) diluted 1:10 in PBSA-T (2.5 µg/ml), followed by Alexa 488-conjugated goat anti-mouse secondary
antibody (catalog no. A-11029; Molecular Probes, Eugene, OR) diluted
1:600 (3.0 µg/ml). Incubation with each antibody was for 1 h at
room temperature. After each antibody incubation cells were treated for
10 min in high salt buffer (28 mM Tris, pH 8.0, 500 mM NaCl, 0.5%
Tween 20) followed by a 10-min wash in PBSA-T. Cells were
counterstained with 0.1 µg/ml 4,6-diamidino-2-phenylindole for
15 min, washed twice with PBS, and stored in PBS at 4°C.
Flow Cytometry
Flow cytometric analysis was performed on a BD Biosciences
FACS-Calibur instrument by using CellQuest and Modfit software. Excitation was at 488 nm. Alexa 488 and 5-(6)-carboxyfluorescein diaetate succinimidyl ester (CFSE; Molecular Probes) emissions were
recorded in the FL-1 channel and propidium iodide (PI) and sulforhodamine 101 (SR; Molecular probes) emissions in the FL-2 channel. For PI staining, cells were harvested by trypsinization, fixed
with ethanol, and stained as described previously (Shichiri et
al., 1993
). BrdU incorporation was detected using anti-BrdU mAb
B44 (BD Biosciences) as recommended by the manufacturer, followed by an
Alexa 488-conjugated secondary antibody. To label cells with CFSE,
exponentially cycling cultures (1-3 × 107
cells) were harvested with trypsin, resuspended in 1 ml of complete DMEM medium containing 10 µM CFSE, and incubated at 37°C for 10 min. Fourteen milliliters of ice cold complete medium was added, mixed
well, and incubation was continued on ice for 5 min. Cells were
recovered by centrifugation (1500 rpm, 4°C, 5 min), resuspended in
complete medium, and an aliquot was immediately analyzed for CFSE
incorporation. The remaining cells were diluted, seeded at <20%
confluence in multiple dishes, and incubated under standard culture
conditions. One dish was harvested by trypsinization every 24 h
for the duration of the experiment. Flow cytometric analysis was done
on live (unfixed) cells. To label cells with SR, cells were fixed with
ethanol as described for PI staining (see above), resuspended in PBS,
stained with 3 µg/ml SR for 5 min., and immediately analyzed by flow cytometry.
Microscopy and Data Analysis
Microscopic observation was performed with a Diaphot inverted microscope (Nikon, Tokyo, Japan) equipped with phase and epifluorescence optics. Histochemically stained cells were counted by visual observation of random fields under 200× magnification. Fluorescently labeled cells were photographed with a Spot-II digital camera (Diagnostics Products, Los Angeles, CA). Cells were scored in random microscopic fields. Means and SDs (n, number of counted fields) were calculated using Microsoft Excel and graphs were generated using Cricket Graph. The minimum total number of cells in each experiment is indicated in the figure legends.
Real-Time Polymerase Chain Reaction (PCR)
RNA was prepared using the RNaequeous-4PCR kit (Ambion, Austin, TX) according to the manufacturer's instructions. One microgram of total RNA was transcribed into cDNA in a 50-µl reaction by using the TaqMan kit (Applied Biosystems, Foster City, CA) and the following conditions: 10 min at 25°C, 30 min at 48°C, and 5 min at 95°C. One microliter of this reaction was used as template in the subsequent PCR reactions by using SYBR Green Master Mix and 0.8 µM (each) of forward and reverse primer for either p21 or GAPDH. PCR was performed in a Prism 7700 sequence detector (Applied Biosystems) according to the manufacturer's instructions. Each sample/primer pair reaction was run in triplicate. Threshold values were determined for each sample/primer pair and average and SD values were calculated. p21 expression was normalized against GAPDH expression.
Determination of the Restriction Point
To determine the restriction point during the M-to-S transitions, cells were synchronized in mitosis by shake-off and plated in 24-well microtiter wells containing serum-supplemented medium (10% CS). Cells were allowed to attach for 2 h, at which point the medium in all but one well was changed to serum-supplemented medium containing BrdU/uridine. The remaining well was carefully rinsed three times with serum-free medium and then replaced with serum-free medium containing BrdU/uridine. At the indicated time points, individual wells were switched to serum-free medium containing BrdU/uridine in an identical manner. The total incubation time after shake-off was kept constant (TGR-1, 24 h; HO15.19, 46 h) at which point the wells were fixed and processed. To determine the restriction point during the G0-to-S transition cells were grown to confluence and subsequently serum starved for 48 h in medium containing 0.25% CS. To initiate cell cycle entry, cells were trypsinized and seeded in 35-mm dishes at ~50% confluence in 10% CS-supplemented medium. Cells were allowed to attach for 2 h, switched to serum-free medium at successive time points, and labeled with BrdU as described above. The experiment was terminated at 28 and 52 h for TGR-1 and HO15.19 cells, respectively. In some experiments, cells were made quiescent by contact inhibition only. In this case, the 48-h period of incubation in medium containing 0.25% CS (above) was replaced with an equivalent incubation period in 10% CS-supplemented medium.
| |
RESULTS |
|---|
|
|
|---|
Pulse labeling of asynchronously cycling, exponential phase cells
with BrdU for 15, 30, or 60 min resulted in ~65 and 30% incorporation in c-myc+/+ and
c-myc
/
cells, respectively (Figure
1A). Flow cytometric analysis of propidium iodide-stained cells gave S-phase values in the range of 46%
for c-myc+/+ cells and 18% for
c-myc
/
cells (Table
1). The discrepancy between the two
measurements can be explained by the poor resolution of the flow
cytometric data between early S and G1 events,
and late S and G2 events. In contrast, because
even a 5-min BrdU pulse resulted in clearly detectable in situ staining
(our unpublished data), this method of analysis accurately
captures very early as well as very late S-phase cells. Combining the
BrdU-estimated S-phase values with the measurement of growth rate gives
calculated S-phase durations of 12.6 and 13.7 h for
c-myc+/+ and
c-myc
/
cells, respectively (Table
2). Using this BrdU-derived data set, the
combined durations of G2 + M + G1 can then be calculated as 6.1 and 29.3 h
for c-myc+/+ and
c-myc
/
cells, respectively. Assuming
that in the flow cytometric data G1 and
G2/M events are inflated equivalently with S
events, increasing S- to the BrdU-derived values would shorten
G1 and G2/M durations to
5.1 and 1.1 h for c-myc+/+ cells, and
to 22.4 and 6.9 h for c-myc
/
cells
(Table 2).
|
|
|
Continuous labeling of asynchronously cycling cells resulted in linear
rates of accumulation with plateaus of 97 and 90% reached in 10 and
24 h by c-myc+/+ and
/
cells, respectively (Figure 1B). Because
the last cells to be labeled correspond to cells that have just exited
S phase at the time that label was added (0 h), the time to reach the
plateau is a measure of the combined lengths of
G2/M + G1. If the line of
accumulation for c-myc
/
cells is
extrapolated to 100% a value of 27.2 h is obtained, which is
somewhat faster than the value of 29.3 h calculated from pulse-labeling values (Table 2). More importantly, however, the fact
that BrdU-positive cells accumulate to an equivalently high plateau in
both c-myc+/+ and
c-myc
/
cultures indicates that the
majority of cells (>90%) are cycling in both cases.
To kinetically assess the duration of G1 phase,
synchronization in M phase was performed by mitotic shake-off. To
minimize physiological perturbations cells were recovered by mechanical agitation from asynchronously cycling, exponential phase cultures without the use of drugs. Continuous labeling resulted in smooth monophasic accumulation profiles and reached a plateau of ~90% for
both c-myc+/+ and
c-myc
/
cells (Figure
2A). The very low initial incorporation
values (2-3%) indicate that the shake-off was minimally contaminated with interphase cells. Fastest G1 transit times
were 2 h for c-myc+/+ cells and
12 h for c-myc
/
cells, but these
events were very few, representing only 3-4% of total cells in both
cases. The midpoints of the transitions fell at 4.9 and 24.7 h for
c-myc+/+ and
c-myc
/
cells, respectively. These
values are in very good agreement with the G1
times of 5.2- and 22.4-h calculated on the basis of pulse labeling of
asynchronous cultures (Table 2). Given that the synchrony of the
c-myc
/
culture seemed to be lower than
that of the c-myc+/+ culture, the
G1 transit time of 24.7 h for
c-myc
/
cells is likely to be an
overestimate. The lower synchrony of c-myc
/
cultures may be due to the fact
that these cells took somewhat longer to attach (our unpublished data).
Nevertheless, the high final incorporation values indicate that the
majority of cells in both cultures were actively cycling. Furthermore,
the smooth profiles of the curves indicate that no significant cohorts
of differentially cycling cells were present in either culture.
|
Additional information on S phase as well as overall cell cycle
durations can be obtained by pulse labeling of mitotic shake-off cultures. If the pulses are short, BrdU incorporation increases early
as cells enter S phase and decreases at later times as cells exit into
G2. In practice, this experiment is affected
strongly by the synchrony of the cultures (the higher the peak the
higher the synchrony). This is because the fastest cells are no longer labeled by later pulses, bringing down the labeling index, whereas other cells are still in S phase. Thus, the time at which labeling begins to decline corresponds roughly to the duration of
G1 + S for the fastest cells. In cultures with
good synchrony the labeling index increases again at later times as
cells begin to enter into a second cell cycle. Fastest
G1 transit times were 2 h for
c-myc+/+ cells and 10 h for
c-myc
/
cells, confirming previous
results (Figure 2B). In c-myc+/+ cultures
labeling first began to fall off at 12 h; given a 2-3 h
G1 phase for the fast cells this results in a
9-10 h S phase, somewhat shorter than the 12.6 h calculated for S
from exponentially cycling cells (Table 2). In
c-myc
/
cultures labeling fell off at
24 h; combined with a 10- to 12-h G1 phase
for the fast cells in this experiment this gives a 12- to 14-h S phase,
in good agreement with the 13.7 h calculated previously. A late
increase in the labeling index occurred clearly for
c-myc+/+ cells at 20 h, and this value
thus corresponds to the length of G1 + S + G2 + M + G1 for the fastest
cells. Again, this is in good agreement with previous data. For
c-myc
/
cells, a small upswing in
labeling was seen at 44 h and beyond. Although this value is also
in good agreement with the reduced proliferation of these cells
measured by other means, the data are compromised by the deterioration
of synchrony in these cultures.
Another method by which valuable kinetic data can be obtained, especially on G2- and S-phase duration, is a procedure referred to as labeled mitoses. In this experiment asynchronously cycling, exponential phase cells are labeled with a single short pulse of BrdU, and at successive time points mitotic figures are scored for the presence or absence of the BrdU label. This procedure has the advantage that it does not use any synchronization steps, which could perturb normal cell cycle progression. The disadvantage is that mitotic figures are few in number, especially in slowly proliferating cultures, making the experiments very time consuming to score.
A rapid rise in BrdU-positive mitoses was seen in both
c-myc+/+ and
/
cultures (Figure 2C), reaching a peak of ~90 and 75%, respectively. The midpoint of the transition was at 3.2 h for
c-myc+/+ cells and 7.5 h for
c-myc
/
cells. These kinetic
measurements of G2 phase duration are somewhat longer than the values of 1.1 and 6.9 h for
c-myc+/+ and
/
cells, respectively, calculated previously on the basis of
pulse-labeling of asynchronous cultures (Table 2). S-phase duration can
be determined by the width of the peak of BrdU-positive mitoses, and
this estimate depends critically on the synchrony of the cultures. The
synchrony with which the pulse-labeled cells proceed though the cycle
is indicated by the steepness of the rise and fall of the peak. By this
measure the progression of c-myc+/+ and
/
cultures were very similar, because even at
later times the down slopes of the peaks are steep and almost parallel.
At the midpoint of the rise the width of the peak (S-phase duration)
was 9.8 h for c-myc+/+ cells and
13.9 h for c-myc
/
cells. These
estimates are in reasonably good agreement with the values of 12.6 and
13.7 h calculated previously (Table 2).
Although labeled mitoses can be followed for more than one cell cycle,
this analysis is limited by the difficulty in finding sufficient
numbers of mitotic cells. An alternative method to determine the
ability of cells to enter into subsequent cell cycles is double
labeling with two distinguishable thymidine analogs; this method can
also provide an independent kinetic measure of overall cell cycle
duration. In this experiment asynchronously cycling, exponential phase
cells were labeled with a single short pulse of CldU, and at successive
time points the cultures were pulse labeled with IdU (Figure 1C). Using
appropriate primary antibodies, the CldU and IdU labels can be
differentially visualized (MATERIALS AND METHODS). Similar to labeled
mitoses, this procedure has the advantage that it does not use any
synchronization steps. At early times, most cells were both CldU and
IdU positive; however, as the CldU-labeled cells progressed through the
cell cycle, the incidence of double-labeled cells decreased. Of
particular interest is the subsequent peak of double-labeled cells,
which represents the reentry into S phase of the CldU-labeled cohort of
cells. This peak reached approximately equivalent values in both
c-myc+/+ and
/
cells (72 and 62%, respectively), indicating that similar numbers of
cells progressed into the second cell cycle in both cultures. One
technical issue affecting this experiment is the relatively low
sensitivity of IdU detection, which caused the fraction of double-labeled cells to be consistently underestimated. The peak of
labeling occurred at 16 h for c-myc+/+
cells and 36 h for c-myc
/
cells.
In summary, this experiment showed that both
c-myc+/+ and
/
cells progressed through the cell cycle uniformly and with comparable synchrony (as evidenced by the relatively steep slopes of the double-label peaks), that equivalent numbers of cells entered a second
cell cycle, and that cell cycle progression was in very good agreement
with proliferation rates measured by standard growth curves.
All the methods mentioned above measure length of S phase at relatively
late time points in the experiment, making the data subject to
uncertainties due to loss of synchrony. Indeed, all S-phase
determinations presented above gave slightly longer values for
c-myc
/
cells than for
c-myc+/+ cells. The rate of genome
replication and thus the length of S phase is determined by both the
number of active origins and the rate of elongation during DNA
synthesis. Very short pulses of BrdU label replication forks and
high-resolution immunofluorescence detection typically results in a
distinctly punctate nuclear appearance. The number of spots, or
"replication centers" is believed to be proportional to the number
of active origins at that point in time (Berezney et al.,
2000
). When exponentially cycling c-myc+/+
and
/
cultures were pulse-labeled with BrdU
for 5 min and processed for immunofluorescence microscopic observation,
no significant differences could be observed even after viewing
numerous images (representative views are shown in Figure
3A). This result indicates that, on
average, c-myc+/+ and
/
cells assemble equivalent numbers of
replication centers during S-phase progression. To further expand this
analysis, BrdU incorporation was quantitatively measured at the single
cell level. Cells were pulse labeled and processed for
immunofluorescence detection as described above, counterstained with
propidium iodide, and analyzed by flow cytometry. In this protocol,
S-phase cells are visualized as an arc of Alexa 488 (BrdU)-positive
cells, with the peak representing the maximum rates of DNA synthesis,
and typically found as a broad zone in mid-S phase. As seen in Figure
3B, the height of the peak was identical in
c-myc+/+ and
/
cells, indicating that both the number of replication centers as well
as the rates of DNA synthesis were equivalent in the two cell lines. In
fact, the only significant difference between the arc profiles was that
the c-myc
/
arc was comprised of far
fewer events. These data indicate that although the number of S-phase
cells is clearly lower in c-myc
/
than
in c-myc+/+ cultures, S-phase progression
is very similar in both.
|
Viewed in aggregate, the above-mentioned cell cycle analyses indicate
that G1 progression is very significantly
compromised in c-myc
/
cells,
G2 is clearly affected but to a much lesser
degree, and S phase seems largely normal (Table
3). G1 phase can be
further subdivided into a postmitotic phase
(G1-pm) and a pre-DNA-synthetic interval
(G1-ps), the two being clearly demarcated by the
restriction (R) point at which cells become committed to continue the
cell cycle without further mitogenic stimulation (Zetterberg et
al., 1995
). To further delineate the G1
phase defect in c-myc
/
cells, cultures
were synchronized at the beginning of G1 by the mitotic shake-off procedure, serum was withdrawn at successive time
points, and entry into S phase was monitored using BrdU labeling. As
shown in Figure 4A,
c-myc+/+ cells passed the R point very
rapidly, the half-point of the transition to serum independence
occurring ~1.5 h after mitotic shake-off. In contrast, 50% of
c-myc
/
cells passed the R point only
8 h after the shake-off. This 5.3-fold defect in progression
through the R point is very similar in magnitude to the four- to
fivefold elongation of G1 phase seen in
c-myc
/
cells (Table 3); however, the
6.5-h G1-pm delay cannot fully account for the
overall 18-h G1-phase elongation. Indeed, when S-phase entry data are superimposed on the restriction point profiles it becomes apparent that the post-R point G1-ps
interval is also significantly elongated in
c-myc
/
cells. If passage through the R
point is expressed as a fraction of the total M- to S-phase interval,
it can be seen that the R point occurs approximately one-third of the
way through G1 in both
c-myc+/+ and
/
cells. In summary, the elongation of G1 phase in
c-myc
/
cells is due to defects in
passage though the R point as well as the subsequent progression toward
S phase.
|
|
Although we did not use drugs to synchronize cells in M phase, the
shake-off procedure could introduce perturbations. We thus examined the
relationship of the R point to S-phase entry in a different
physiological setting, namely, synchronization in
G0 phase by a combination of contact inhibition
and serum deprivation, and subsequent release into the cell cycle by
dilution into serum-containing medium. As shown in Figure 4D,E, both
c-myc+/+ and
c-myc
/
passed the R point at
approximately two-thirds (58-60%) of the total S-phase progression
time. The half point of S-phase entry was at 16.8 h and 22 h
for c-myc+/+ and
c-myc
/
cells, respectively. We have
previously measured S phase entry for
c-myc
/
cells at 32 h under
conditions where quiescent cells were stimulated with serum but not
trypsinized and reseeded at the time of stimulation. The additional
relief of contact inhibition results in a shortening of the
G0
]S transition in
c-myc
/
cells but has little or no
effect on c-myc+/+ cells (Figure 6C);
nevertheless, the delays in S-phase entry as well as in passage through
the R point in c-myc
/
cells are clearly discernible.
While this work was in progress, a report by Eick and colleagues
(Holzer et al., 2001
) presented data that
c-myc
/
cultures are a mixture of very
slowly cycling (or even noncycling) cells and cells that cycle at
essentially normal (c-myc+/+) rates.
Because our data presented above are not compatible with that
interpretation, we wished to address possible confounding factors.
Because we had relied extensively on BrdU labeling methods, we examined
whether BrdU incorporation into cellular DNA could have affected cell
cycle progression under our experimental conditions. BrdU and its
derivatives have been documented to perturb the cell cycle and activate
p53 (Rieber et al., 1996
; Michishita et al., 1999
; Peng et al., 2001
; Suzuki et al., 2001
),
but these effects have been associated with exposures to higher
concentrations of BrdU and for longer times than the conditions used
herein. We labeled c-myc+/+ and
c-myc
/
cells for 48 h with BrdU,
harvested the cells, stained them with propidium iodide, and subjected
them to a flow cytometric analysis of cell cycle distribution. No
differences were apparent compared with the cell cycle profiles of
unlabeled, exponentially cycling control cells (our unpublished
data). BrdU has been reported to induce both p53-dependent and
p53-independent arrests (Rieber et al., 1996
; Peng et
al., 2001
), but the induction of
p21Cip1/Waf1 gene expression seems to be a
universal hallmark of the BrdU response (Rieber et al.,
1996
; Suzuki et al., 2001
). We therefore analyzed
BrdU-labeled cells by real-time quantitative PCR for changes in p21
mRNA abundance (Figure 5A); again, no
changes were observed. It thus seems that BrdU labeling under the
conditions used herein does not elicit cell cycle perturbations.
|
We wished to further examine, using a completely distinct method of
analysis, whether c-myc
/
cultures
consist of separate populations of cycling and noncycling cells. To
this end, we used a method that measures the dilution of the vital dye
CFSE. CFSE is a fluorescent dye that penetrates cell membranes and is
metabolized and trapped within cells. Because CFSE is evenly
distributed to daughter cells, the fluorescence intensity decreases by
half with each cell division. This method has been widely used in
immunology (Lyons, 1999
) and neurobiology (Groszer et al.,
2001
) to track cells both in vitro and in vivo for up to 10 generations. Dye dilution was found to be completely uniform for both
c-myc+/+ and
c-myc
/
cells (Figure 5, B and C).
Cohorts of noncycling (or slowly cycling) cells would be visualized as
discrete peaks (or shoulders) at higher fluorescence intensity values.
However, the peaks were found to be symmetrical and of the same width
in both cultures at all time points. Furthermore, the rate of dye
dilution (decrease in fluorescence intensity as a function of time) was
consistent with the doubling times measured by standard growth curves.
We therefore conclude that under our exponential growth conditions both
c-myc+/+ and
c-myc
/
cultures are uniformly composed
of continuously cycling cells.
We subsequently sought possible explanations for the discrepancy
between our data and that reported by Holzer et al. (2001)
. Their study used time lapse photography of cells seeded at relatively high densities; it is thus conceivable that
c-myc
/
cells are capable of a limited
growth spurt under these conditions, perhaps due to effects such as
conditioning of the medium, deposition of extracellular matrix, or even
transient cell-cell contact. To address these possibilities
c-myc+/+ and
/
cells were seeded at low density, propagated continuously with frequent
media changes until growth arrest due to high density was reached, and
monitored at regular intervals for cell number as well as BrdU
incorporation. As shown in Figure 6A,
both cultures grew at constant rates and leveled off at equivalent cell
densities (~1 × 105
cells/cm2). BrdU incorporation remained
relatively constant throughout the exponential phase (Figure 6B) at
close to previously observed values. It is noteworthy that if the
culture medium was replenished at less frequent intervals (4 d instead
of 2 d) c-myc
/
cultures reached
two- to threefold lower saturation densities than
c-myc+/+ cultures (our unpublished
data). It thus seems that the greater sensitivity of
c-myc
/
cultures to contact inhibition
reported by Holzer at al. (2001)
was due to suboptimal
culture conditions, most likely medium depletion. It is also noteworthy
that the cycling rates of c-myc+/+ cells in
the Holzer at al. (2001)
study were uncharacteristically slow (28 h).
|
In our search for conditions that could at least partially equalize the
proliferation rates of c-myc+/+ and
c-myc
/
cells, we noticed that in the
experiment to determine the R point during the
G0
S transition by using serum-starved and
restimulated cells (Figure 4B), a significant fraction (up to 30%) of
c-myc
/
cells entered S phase with
kinetics that matched the fastest c-myc+/+
cells. To further explore this phenomenon, we used another method of
G0 synchronization, namely, contact inhibition
without concomitant serum deprivation. In most cell lines (including
Rat-1) this method is known to yield inferior G0
arrest compared with serum deprivation, and is thus seldomly used. To
our surprise, when contact inhibited cells were released into the cycle
(Figure 4C), c-myc+/+ and
c-myc
/
cultures entered S phase at
equivalent times (c-myc
/
cells were
even somewhat faster). Both c-myc+/+ and
c-myc
/
cells were affected by this
regimen: relative to synchronization by serum deprivation,
c-myc+/+ cells were slowed down and
c-myc
/
cells were accelerated. It was
especially striking that these differences were largely caused by
changes in the duration of G1-ps, which was
lengthened in c-myc+/+ cells and
dramatically shortened in c-myc
/
cells,
such that they entered S phase almost immediately after passing the R
point. In contrast, the interval from G0 to the R
point was relatively unaffected in each cell line by the different synchronization regimens.
Because duration of G1-ps is not affected by
mitogens but is the cell cycle interval characterized by accumulation
of mass, we examined cell size under our growth and
G0 arrest conditions. Although such
determinations are frequently made by measuring forward scatter in a
flow cytometer, we found this method to be unreliable. We believe this
is because forward scatter is affected by parameters such as cell
shape, surface properties, and internal structure. We therefore used a
flow cytometric method that measures total cellular protein by using
the general protein dye sulforhodamine 101 (Engelhard, 1997
).
Exponentially cycling c-myc+/+ and
c-myc
/
cells had very similar protein
content (Figure 7A), which is consistent
with previous data showing that they have equivalent cell size (Mateyak
et al., 1997
). Serum-starved cells became smaller, as
previously reported (Larsson et al., 1986
), although this
effect was much less pronounced in
c-myc
/
cells (Figure 7B). In addition,
c-myc
/
cultures accumulated significant
numbers of larger cells, as indicated by a prominent shoulder on the
high intensity side of the peak (the data were carefully gated on
single cells to exclude aggregates). The difference in cell size
between c-myc+/+ and
c-myc
/
cells was even more pronounced
if cultures were allowed to reach confluence in the presence of
full-serum supplementation (Figure 7C).
|
A simple explanation for the observed rapid S-phase entry of
c-myc
/
cells (Figure 4C) is that rates
of G1-ps progression are strongly influenced by
the size of the starting cell. In other words, large cells need a
minimal G1-ps to reach critical size for
progression into S phase. Although we have not followed cells all the
way from G0 into mitosis, our data that
G1 accounts for most the difference in cell cycle
duration between c-myc+/+ and
c-myc
/
cells, as well as other studies
showing that most cell cycle variability is due to changing lengths of
G1-ps (Zetterberg and Larsson, 1991
), would
predict that c-myc
/
cells are capable
of relatively fast cell cycle transit times under some conditions.
Furthermore, we have shown that rapid cell cycle transit is correlated
with large cell mass, and that cell mass is positively correlated with
high-density culture in the presence of full serum supplementation. We
have observed that these conditions arise if cultures that are not
continuously maintained at subconfluent conditions, especially with
c-myc
/
cells that tend to aggregate in
larger islands and patches.
| |
DISCUSSION |
|---|
|
|
|---|
The series of labeling experiments presented in this communication
show that the reduced proliferation rate previously documented for
c-myc
/
cells is due primarily due to a
very significant lengthening of G1 phase (four-
to fivefold) as well as a more minor lengthening of
G2 phase (twofold). S-phase duration was found to
be largely unaffected. G1 phase is comprised of a
postmitotic interval (G1-pm) and a
pre-DNA-synthetic interval (G1-ps), the two being
separated by the restriction (R) point (Zetterberg et al.,
1995
). The second significant finding of this study is that both the
G1-pm and G1-ps intervals
were equally compromised in c-myc
/
cells. Finally, we showed that the majority of cells in
c-myc
/
cultures during asynchronous,
exponential phase growth display uniform cell cycles; in other words,
no evidence was found for the existence of differentially cycling
cohorts of cells.
Data from all experiments have been combined (Table 3) to derive what
we consider to be the best approximations of cell cycle phase
durations, using the following considerations. First, all methods,
including direct labeling after mitotic shake-off, gave G1 phase durations that were in close agreement
for both cell lines. Second, although flow cytometric quantification of
BrdU incorporation did not pick up significant differences between c-myc+/+ and
/
cells, kinetic labeling methods showed a slight S-phase lengthening in
c-myc
/
cells. Therefore, S-phase
durations were adjusted to 11 and 13 h for
c-myc+/+ and
c-myc
/
cells, respectively. Although
probably real, this difference is very small (1.2-fold) with respect to
overall S-phase duration. Third, the kinetic determination of
G2 phase using the labeled mitoses method was
considered the most direct and reliable, and these values were thus
used preferentially. Fourth, overall cell cycle durations were set to
19 and 43 h for c-myc+/+ and
c-myc
/
cells, respectively, and
individual cell cycle phases were adjusted accordingly. These values
were used because they were consistently observed with the batch of
serum used in the experiments reported herein. It should be noted,
however, that proliferation can be very sensitive to culture
conditions, and that over several years we have observed growth rates
in the range of 17-23 h and 42-60 h for
c-myc+/+ and
c-myc
/
cells, respectively.
Under most conditions normal mammalian cells exhibit a state of
balanced growth such that cellular mass (mostly protein) doubles exactly during each cell cycle (Zetterberg and Larsson, 1991
). It is
commonly observed that cells can adjust cell cycle progression in
response to changes in growth (accumulation of mass) to maintain a
constant size at the next cell division. Because rates of protein synthesis can change dramatically in response to many environmental conditions, the maintenance of a relatively constant cell size during
proliferation under changing conditions is an indication of the
existence of cell size monitoring processes. Experiments showing that
growth and proliferation could be uncoupled under some conditions led
to proposals for distinct "protein" and "chromosome" cell
cycles (Baserga, 1984
). For example, because withdrawal of mitogenic
stimulation results in a drop in protein synthesis, cells that have
passed the restriction point will progress to mitosis and divide at a
smaller size than normal. Although the mechanisms that coordinate cell
growth and cell cycle progression in mammalian cells are poorly
understood, it has become apparent that the G1
phase interval between the restriction point and S phase
(G1-ps) can vary significantly in length under
different growth conditions (and also between different cells in the
same culture) and may be the primary point at which adjustments in cell
cycle progression can be made in response to variations in cell mass
(Ekholm et al., 2001
).
c-Myc has been associated with promoting cell proliferation as well as
cell growth. Under some conditions Myc is sufficient in triggering
progression into S phase (Eilers et al., 1991
), whereas
others have reported that Myc acts as a immediate-early competence
factor that cooperates with platelet-poor plasma (Kaczmarek et
al., 1985
). Both effects are best explained by direct effects on
cell cycle progression. On the other hand, several recent examples point to an important, perhaps primary, role for c-Myc in promoting macromolecular synthesis and accumulation of cell mass (Iritani and
Eisenman, 1999
; Johnston et al., 1999
; Beier et
al., 2000
; Greasley et al., 2000
; Kim et
al., 2000
). The observation that rRNA and protein synthesis are
threefold slower in c-myc null rat fibroblasts yet the cells
maintain normal size (Mateyak et al., 1997
) can be explained
by the existence of cell size checkpoints that slow cell cycle
progression during balanced growth.
The fact that loss of c-Myc causes a significant lengthening of
G1-ps is most consistent with a role of c-Myc in
cell growth. Progression through this cell cycle interval is
independent of mitogenic signaling (Pardee, 1989
) and is the time when
most of the macromolecular synthesis in preparation for S phase takes place (Zetterberg et al., 1995
). Not surprisingly, ribosomal
biogenesis is rapid during G1-ps (Grummt, 1999
).
c-myc
/
cells accumulate rRNA at a
reduced rate (Mateyak et al., 1997
), and both ribosomal
processing factors and translation initiation factors have been
reported to be transcriptional targets of c-Myc (Schmidt, 1999
; Coller
et al., 2000
; Greasley et al., 2000
). Neither ribosomal biogenesis nor rates of translation have been directly examined in c-myc
/
cells, however, the
overall rate of protein synthesis was found to be reduced by some
threefold (Mateyak et al., 1997
). Although the length of
G1-ps would be expected to be strongly affected by rates of protein synthesis, a variety of metabolic enzymes have also
been implicated as c-Myc targets (Dang, 1999
; Coller et al.,
2000
; Guo et al., 2000
) and may well play a role in
G1-ps progression.
On the other hand, the observed defect in progression through the R
point is more consistent with a direct role of c-Myc on the cell cycle
machinery. Several cell cycle regulators active in early
G1 phase, including p27 (Mateyak et
al., 1999
; Yang et al., 2001
), gadd45 (Marhin et
al., 1997
; Bush et al., 1998
), cyclin D2 (Bouchard
et al., 1999
), and Cdk4 (Hermeking et al., 2000
) have been implicated as transcriptional targets of c-Myc. Indeed, the
earliest known defect in cell cycle progression in
c-myc
/
cells is a very significant (10- to 15-fold) reduction in cyclin D-Cdk4/6
activation (Mateyak et al., 1999
; Obaya et al.,
2002
). Although passage through the R point is dependent on protein
synthesis (Pardee, 1989
), rapid ribosome biogenesis and protein
synthesis does not occur until later in G1.
Because cell mass does not increase during G1-pm
(Zetterberg and Larsson, 1991
), it can be argued that defects in cell
growth caused by lack of c-Myc would be unlikely to severely affect
progression up to the R point. However, the role of c-Myc in R point
progression requires closer scrutiny. First, reports of the
competence-promoting activity of c-Myc were based on overexpression and
may not reflect a physiological function. Second, although rRNA
synthesis is not up-regulated until G1-ps (Ciarmatori et al., 2001
; Voit and Grummt, 2001
), protein
synthesis at early times in G1 has not been
directly compared between c-myc+/+ and
/
cells. Thus, it is possible that reduced
translation in c-myc
/
cells may play a
role in R point progression.
Several lines of evidence point to multiple roles for c-Myc in cell
cycle progression. Perhaps the most striking is the finding that
c-myc null cells have never been observed to revert to
faster growth, and concerted efforts to identify downstream targets by functional complementation with retroviral cDNA libraries have been
uniformly unsuccessful (Berns et al., 2000
; Nikiforov
et al., 2000
). We show herein that loss of c-Myc results
predominantly in a G1 phase defect, and that
progression through G1-pm and
G1-ps are equally affected. These results are
best explained by a model in which c-Myc directly affects cell growth
(accumulation of mass) and cell proliferation (the cell cycle
machinery) by independent pathways. Recent results that implicate both
some metabolic enzymes and cell cycle regulators as direct
transcriptional targets of c-Myc are consistent with this hypothesis.
| |
ACKNOWLEDGMENTS |
|---|
We gratefully acknowledge the excellent technical assistance of Jennifer Rosenberg. This project was supported by a National Institutes of Health research grant GM-41690 (to J.M.S.).
| |
FOOTNOTES |
|---|
* Corresponding author. E-mail address: john_sedivy{at}brown.edu.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02-10-0649. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02-10-0649.
| |
REFERENCES |
|---|
|
|
|---|